Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule - Related Studies

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

This study has been completed.

Study NCT00460486. Last updated on March 27, 2008. Information provided by Baxter Healthcare Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Encephalitis, Tick-Borne

2	Additional conditions recognized in this trial
		Encephalitis

3	More general conditions related to this trial
		Arbovirus Infections
		Brain Diseases
		Central Nervous System Diseases
		Central Nervous System Infections
		Central Nervous System Viral Diseases
		Encephalitis, Arbovirus
		Encephalitis, Viral
		Flaviviridae Infections
		Flavivirus Infections
		Nervous System Diseases
		RNA Virus Infections
		Tick-Borne Diseases
		Virus Diseases

4	Additional drug interventions recognized in this trial
		Formaldehyde

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Disinfectants
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Baxter Healthcare Corporation